Genome Compiler Corp.

🗓 Founded 2011👥 5 employees💰 Last funded Mar 2014
Biotechnology Research🌐 genomecompiler.com
Website LinkedIn
Genome Compiler Corporation (GCC) is a Synthetic Biology venture. Our aim is to build a best-in-class CAD system and a synthetic DNA marketplace for the new and growing community of biological designers around the world. Genome Compiler provides an intuitive all-in-one software platform for genetic engineers, molecular and synthetic biologists. We supply a comprehensive set of tools for DNA design & visualization, data management and collaboration. Using Genome Compiler, you will benefit from an optimal design experience with our extensive suite of advanced design tools, a variety of plasmids and parts repositories, direct connections to an array of DNA synthesis providers and lab automation services, all in one platform.
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2011
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Genome Compiler Corp.?
Genome Compiler Corp. has 2 investors on record on gritt.io, 2 mid-stage.
When did Genome Compiler Corp. last raise funding?
The most recent investment in Genome Compiler Corp. recorded on gritt.io was in March 2014.
When was Genome Compiler Corp. founded?
Genome Compiler Corp. was founded in 2011.
What industry is Genome Compiler Corp. in?
Genome Compiler Corp. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.